diphenoxylate hydrochloride and atropine sulfate
Generic: diphenoxylate hydrochloride and atropine sulfate
Labeler: leading pharma, llcDrug Facts
Product Profile
Brand Name
diphenoxylate hydrochloride and atropine sulfate
Generic Name
diphenoxylate hydrochloride and atropine sulfate
Labeler
leading pharma, llc
Dosage Form
TABLET
Routes
Active Ingredients
atropine sulfate .025 mg/1, diphenoxylate hydrochloride 2.5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
69315-910
Product ID
69315-910_af054a1c-a0a1-4097-8170-3e7b070ad830
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA213413
DEA Schedule
cv
Listing Expiration
2026-12-31
Marketing Start
2020-03-15
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
69315910
Hyphenated Format
69315-910
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
diphenoxylate hydrochloride and atropine sulfate (source: ndc)
Generic Name
diphenoxylate hydrochloride and atropine sulfate (source: ndc)
Application Number
ANDA213413 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .025 mg/1
- 2.5 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (69315-910-01)
- 90 TABLET in 1 BOTTLE (69315-910-09)
- 1000 TABLET in 1 BOTTLE (69315-910-10)
Packages (3)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "af054a1c-a0a1-4097-8170-3e7b070ad830", "openfda": {"upc": ["0369315910092", "0369315910016", "0369315910108"], "unii": ["03J5ZE7KA5", "W24OD7YW48"], "rxcui": ["1190572"], "spl_set_id": ["1c188bc9-7c21-4717-94a0-cdfb581fb776"], "manufacturer_name": ["Leading Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (69315-910-01)", "package_ndc": "69315-910-01", "marketing_start_date": "20200315"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (69315-910-09)", "package_ndc": "69315-910-09", "marketing_start_date": "20200315"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (69315-910-10)", "package_ndc": "69315-910-10", "marketing_start_date": "20200315"}], "brand_name": "Diphenoxylate Hydrochloride and Atropine Sulfate", "product_id": "69315-910_af054a1c-a0a1-4097-8170-3e7b070ad830", "dosage_form": "TABLET", "pharm_class": ["Anticholinergic [EPC]", "Antidiarrheal [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "69315-910", "dea_schedule": "CV", "generic_name": "diphenoxylate hydrochloride and atropine sulfate", "labeler_name": "Leading Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Diphenoxylate Hydrochloride and Atropine Sulfate", "active_ingredients": [{"name": "ATROPINE SULFATE", "strength": ".025 mg/1"}, {"name": "DIPHENOXYLATE HYDROCHLORIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA213413", "marketing_category": "ANDA", "marketing_start_date": "20200315", "listing_expiration_date": "20261231"}